Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CHCHD4 (Coiled-coil-helix-coiled-coil-helix domain-containing protein 4), also known as MIA40, is a highly conserved, redox-active oxidoreductase enzyme located in the mitochondrial intermembrane space[2][5]. It acts as a central component of the mitochondrial disulfide relay system, where it serves as a chaperone that catalyzes the import, oxidative folding, and assembly of numerous essential small cysteine-rich proteins—critical for the biogenesis of the mitochondrial respiratory chain complexes and other mitochondrial functions[5][2][3]. CHCHD4 recognizes mitochondrial targeting signals in substrate proteins, forms transient intermolecular disulfide bonds through its CPC motif, and is subsequently reoxidized by the sulfhydryl oxidase GFER/Erv1 in a relay that supports continual catalytic activity[2][5]. Disruption of CHCHD4 in animal models results in defects in mitochondrial respiration, iron homeostasis, and multiple human disease phenotypes, highlighting its essential and non-redundant role in cell metabolism and survival[2][4][5]. Currently, there are no clinically approved drugs targeting CHCHD4, but its central role in mitochondrial protein import and redox biology makes it an attractive putative therapeutic target for mitochondrial diseases, neurodegeneration, and cancer[5][2].
Induction of oxidative folding by disulfide relay system; Protein import facilitation via oxidation of substrate thiols
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coiled-coil-helix-coiled-coil-helix domain-containing protein 4 (CHCHD4).